NSE

Abbott India LimitedABBOTINDIA

ABBOTINDIAAbbott India Limited₹25,955▼ 0.42% today

Nifty Midcap 150

Abbott India is the listed Indian arm of Abbott, focused on branded pharma.

Key products	Branded formulations across GI, metabolics, women's health and CNS.
Geography	India.
Competitors	Sun Pharma, USV, Mankind.

AI-generated overview — verify before relying on it.

Net institutional flow

No institutional deals

Institutional buyers

0 in / 0 out

High-impact filings

0 · tilt Neutral

Next corporate action

Dividend - Rs 475 Per Share

ex 2025-07-25

Competitive landscape — the read

vs mapped peers · ALL

1M 3M 6M 1Y 2Y All

Institutional money is backing ALKEM hardest (+₹1,013.7 Cr net). ABBOTINDIA ranks #2 of 9 on flow (net buying +₹0 Cr). Filing momentum favours ZYDUSLIFE (+1). News & social buzz is most positive on DRREDDY.

#	Company	Inst. flow ₹Cr	Deals	Hi-impact	Filing mom.	Buzz	News
1	ALKEM	+₹1,013.7 Cr	13	—	—	-2	6
2	ABBOTINDIAThis	—	—	—	—	+2	17
3	CIPLA	—	—	—	—	+19	44
4	DRREDDY	—	—	—	—	+20	46
5	SUNPHARMA	—	—	—	—	+15	45
6	TORNTPHARM	—	—	—	—	—	—
7	LUPIN	—	—	—	—	—	—
8	ZYDUSLIFE	—	—	1	+1	—	—
9	AUROPHARMA	—	—	—	—	—	—

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

SWOT

Strengths

• [object Object]
• [object Object]

Weaknesses

• [object Object]
• [object Object]

Opportunities

• [object Object]
• [object Object]

Threats

• [object Object]
• [object Object]

AI-generated from our data — verify before relying on it.

Timeline — ABBOTINDIA day by day

1M 3M 6M 1Y 2Y All

2026-06-15NewsAbbott India sets July 24 record date for ₹656 dividendTopic · India.
2026-05-25NewsAbbott India Limited Appoints Swati Pathak as Associate Director - Operations, Effective June 1, 202626Topic · India.
2026-05-13NewsAbbott India FY26 Results Published in Newspapers Under Regulation 47scanx.trade
2026-02-27NewsAbbott seals distribution pact with Novo to market Ozempic second brand in IndiaTopic · India.
2026-02-03NewsAbbott India Limited Schedules Board Meeting for February 12, 2026 to Review Q3FY26 Financial Resultsscanx.trade
2026-01-19NewsGetting In Cheap On Abbott India Limited (NSE:ABBOTINDIA) Is Unlikelysimplywall.st
2025-12-27NewsAbbott India announces key changes to its boardTopic · India.
2025-12-24NewsAbbott India Limited (NSE:ABBOTINDIA) stock most popular amongst public companies who own 75%, while individuasimplywall.st
2025-12-12NewsLupin Manufacturing Solutions and PolyPeptide Announce Strategic Alliance to Scale Global Peptide Supply ChainTopic · metabolics
2025-11-25NewsAbbott India appoints Vinutha Mufti as new Director, Business Human ResourcesTopic · India.
2025-11-24NewsAbbott India Limited's (NSE:ABBOTINDIA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Ssimplywall.st
2025-07-25ActionDividend - Rs 475 Per ShareDividend
2025-03-06NewsEris Lifesciences appoints Murari Ranganathan to spearhead Cardiometabolic BusinessTopic · metabolics
2025-02-28NewsAbbott India: Resignation of Sridhar Kadangode as CFO, Murari Ranganathan as Commercial Director -...Topic · metabolics
2025-01-03NewsAbbott India appoints Prithwish K Banerji as Commercial Director - Women’s Health, Metabolics and InternationaTopic · metabolics
2024-07-19ActionDividend - Rs 410 Per ShareDividend
2024-03-14NewsBiocon Biologics, Eris Lifesciences announce long-term collaboration to expand patient access to metabolics,..Topic · metabolics
2022-01-08NewsABBOTT INDIA SHARE PRICE TODAYICICI Direct
2020-04-27NewsICMR agreed to pay 2.5 times the price for rapid test kits, Delhi HC judgment showsTopic · metabolics

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.